Peer Reviewed Publications
- Eur Urol 2025 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
- Eur Urol 2025 European Association of Urology Guidelines on Renal Cell Carcinoma The 2025 Update
- Eur Urol Oncol 2025 Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy A Systematic Review by the EAU RCC Guidelines Panel
- Eur Urol 2023 European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist’s Point of View
- Eur Urol Open Sci 2023 Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups
- Eur Urol 2022 European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update
- Eur Urol 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma 2021
- Urol Oncol 2022 Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)
- Eur Urol Oncol 2021 The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery—Results from RECUR Consortium
- Eur Urol Oncol 2020 Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guide
- Eur Urol Oncol 2020 Management of Sporadic Renal Angiomyolipomas A Systematic Review
- Cochrane Database of Systematic Reviews 2020 Targeted therapy for metastatic renal cell carcinoma (Review)